A blueprint for tumor-infiltrating B cells across human cancers

Jiaqiang Ma(Fudan University), Yingcheng Wu(Fudan University), Lifeng Ma(Institute for Stem Cell Biology and Regenerative Medicine), Xupeng Yang(Fudan University), Tiancheng Zhang(Fudan University), Guohe Song(Fudan University), Teng Li, Ke Gao(Fudan University), Xia Shen(Fudan University), Jian Lin(Fudan University), Yamin Chen, Xiaoshan Liu, Yuting Fu(Institute for Stem Cell Biology and Regenerative Medicine), Xixi Gu, Zechuan Chen, Shan Jiang, Dongning Rao(Fudan University), Jiaomeng Pan(Fudan University), Shu Zhang(Fudan University), Jian Zhou(Fudan University), Chen Huang(Shanghai First People's Hospital), Si Shi(Fudan University Shanghai Cancer Center), Jia Fan(Fudan University), Guoji Guo(Institute for Stem Cell Biology and Regenerative Medicine), Xiaoming Zhang, Qiang Gao(Fudan University)
Science
May 2, 2024
Cited by 194

Abstract

B lymphocytes are essential mediators of humoral immunity and play multiple roles in human cancer. To decode the functions of tumor-infiltrating B cells, we generated a B cell blueprint encompassing single-cell transcriptome, B cell-receptor repertoire, and chromatin accessibility data across 20 different cancer types (477 samples, 269 patients). B cells harbored extraordinary heterogeneity and comprised 15 subsets, which could be grouped into two independent developmental paths (extrafollicular versus germinal center). Tumor types grouped into the extrafollicular pathway were linked with worse clinical outcomes and resistance to immunotherapy. The dysfunctional extrafollicular program was associated with glutamine-derived metabolites through epigenetic-metabolic cross-talk, which promoted a T cell-driven immunosuppressive program. These data suggest an intratumor B cell balance between extrafollicular and germinal-center responses and suggest that humoral immunity could possibly be harnessed for B cell-targeting immunotherapy.


Related Papers